The central nervous norepinephrine network links a diminished sense of emotional well-being to an increased body weight

Int J Obes (Lond). 2016 May;40(5):779-87. doi: 10.1038/ijo.2015.216. Epub 2015 Oct 20.

Abstract

Objectives: The neurobiological mechanisms linking obesity to emotional distress remain largely undiscovered.

Methods: In this pilot study, we combined positron emission tomography, using the norepinephrine transporter (NET) tracer [(11)C]-O-methylreboxetine, with functional connectivity magnetic resonance imaging, the Beck depression inventory (BDI), and the impact of weight on quality of life-Lite questionnaire (IWQOL-Lite), to investigate the role of norepinephrine in the severity of depression (BDI), as well as in the loss of emotional well-being with body weight (IWQOL-Lite).

Results: In a small group of lean-to-morbidly obese individuals (n=20), we show that an increased body mass index (BMI) is related to a lowered NET availability within the hypothalamus, known as the brain's homeostatic control site. The hypothalamus displayed a strengthened connectivity in relation to the individual hypothalamic NET availability to the anterior insula/frontal operculum, as well as the medial orbitofrontal cortex, assumed to host the primary and secondary gustatory cortex, respectively (n=19). The resting-state activity in these two regions was correlated positively to the BMI and IWQOL-Lite scores, but not to the BDI, suggesting that the higher the resting-state activity in these regions, and hence the higher the BMI, the stronger the negative impact of the body weight on the individual's emotional well-being was.

Conclusions: This pilot study suggests that the loss in emotional well-being with weight is embedded within the central norepinephrine network.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Body Mass Index
  • Depression / psychology*
  • Emotions*
  • Female
  • Germany
  • Humans
  • Hypothalamus / metabolism
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Norepinephrine / metabolism*
  • Norepinephrine Plasma Membrane Transport Proteins / metabolism
  • Obesity, Morbid / metabolism*
  • Obesity, Morbid / physiopathology
  • Obesity, Morbid / psychology*
  • Pilot Projects
  • Positron-Emission Tomography
  • Psychometrics
  • Quality of Life
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Weight Gain / physiology*
  • Young Adult

Substances

  • Norepinephrine Plasma Membrane Transport Proteins
  • Radiopharmaceuticals
  • Norepinephrine